Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan L Longo

Showing results (61-70 of 219) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|December 14, 2016
PARP Inhibitors in Ovarian Cancer TreatmentDavid R Spriggs, Dan L Longo
The New England Journal of Medicine|May 28, 2015
Precision medicine--personalized, problematic, and promisingJ Larry Jameson, Dan L Longo
The New England Journal of Medicine|October 16, 2024
Therapy for Hodgkin's Lymphoma - Can It Get Any Better?James O Armitage, Dan L Longo
The New England Journal of Medicine|September 29, 2015
Cautious Optimism for Offspring of Women with Cancer during PregnancyMichael F Greene, Dan L Longo
The New England Journal of Medicine|November 24, 2021
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and VaccinationWilliam J Murphy, Dan L Longo
The New England Journal of Medicine|December 23, 2021
Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the OtherEric J Rubin, Dan L Longo
The New England Journal of Medicine|June 27, 2018
Exploiting Viruses to Treat DiseasesDan L Longo, Lindsey R Baden
The Oncologist|April 11, 2025
Primum succurrere; first hasten to helpDan L Longo, James O Armitage
Molecular Cancer Research : MCR|December 7, 2010
Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptorsGang Chen, Paritosh Ghosh, Dan L Longo
Hospital Practice|March 1, 1979
The Frankenstein monster and recombinant DNAEdward A Adelberg, Dan L Longo, Waclaw Szybalski
Pageof 22

Showing results (61-70 of 219) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|December 14, 2016
PARP Inhibitors in Ovarian Cancer TreatmentDavid R Spriggs, Dan L Longo
The New England Journal of Medicine|May 28, 2015
Precision medicine--personalized, problematic, and promisingJ Larry Jameson, Dan L Longo
The New England Journal of Medicine|October 16, 2024
Therapy for Hodgkin's Lymphoma - Can It Get Any Better?James O Armitage, Dan L Longo
The New England Journal of Medicine|September 29, 2015
Cautious Optimism for Offspring of Women with Cancer during PregnancyMichael F Greene, Dan L Longo
The New England Journal of Medicine|November 24, 2021
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and VaccinationWilliam J Murphy, Dan L Longo
The New England Journal of Medicine|December 23, 2021
Covid-19 mRNA Vaccines - Six of One, Half a Dozen of the OtherEric J Rubin, Dan L Longo
The New England Journal of Medicine|June 27, 2018
Exploiting Viruses to Treat DiseasesDan L Longo, Lindsey R Baden
The Oncologist|April 11, 2025
Primum succurrere; first hasten to helpDan L Longo, James O Armitage
Molecular Cancer Research : MCR|December 7, 2010
Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptorsGang Chen, Paritosh Ghosh, Dan L Longo
Hospital Practice|March 1, 1979
The Frankenstein monster and recombinant DNAEdward A Adelberg, Dan L Longo, Waclaw Szybalski
Pageof 22